American Century Companies’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-71,165
Closed -$364K 2885
2024
Q3
$364K Buy
71,165
+25,603
+56% +$131K ﹤0.01% 2577
2024
Q2
$165K Buy
45,562
+7,039
+18% +$25.5K ﹤0.01% 2762
2024
Q1
$124K Sell
38,523
-782,914
-95% -$2.51M ﹤0.01% 2840
2023
Q4
$4.03M Sell
821,437
-2,881
-0.3% -$14.1K ﹤0.01% 1468
2023
Q3
$4.49M Buy
824,318
+86,478
+12% +$471K ﹤0.01% 1371
2023
Q2
$4.95M Buy
737,840
+70
+0% +$470 ﹤0.01% 1317
2023
Q1
$6.51M Buy
737,770
+159,372
+28% +$1.41M 0.01% 1168
2022
Q4
$4.42M Buy
578,398
+176,441
+44% +$1.35M ﹤0.01% 1267
2022
Q3
$2.86M Buy
401,957
+220,266
+121% +$1.57M ﹤0.01% 1311
2022
Q2
$1.47M Buy
181,691
+2,065
+1% +$16.7K ﹤0.01% 1533
2022
Q1
$2.49M Sell
179,626
-1,878
-1% -$26.1K ﹤0.01% 1335
2021
Q4
$5.09M Buy
181,504
+57,642
+47% +$1.62M ﹤0.01% 1051
2021
Q3
$4.21M Buy
123,862
+142
+0.1% +$4.83K ﹤0.01% 1074
2021
Q2
$5.06M Buy
+123,720
New +$5.06M ﹤0.01% 988
2021
Q1
Sell
-948,837
Closed -$56.1M 2195
2020
Q4
$56.1M Sell
948,837
-48
-0% -$2.84K 0.04% 372
2020
Q3
$46.1M Buy
948,885
+147,714
+18% +$7.18M 0.04% 366
2020
Q2
$38.8M Buy
+801,171
New +$38.8M 0.04% 387
2019
Q3
Sell
-177,091
Closed -$8.55M 1206
2019
Q2
$8.55M Buy
+177,091
New +$8.55M 0.01% 665